Eargo closes first tranche investment of $100 million from patient square capital

San jose, calif., july 05, 2022 (globe newswire) -- eargo, inc. (nasdaq: ear) (the “company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 million aggregate principal amount of senior secured convertible notes to patient square capital on june 28, 2022 (the “first tranche investment”).
EAR Ratings Summary
EAR Quant Ranking